Perrigo - 33 Year Stock Price History | PRGO
- The all-time high Perrigo stock closing price was 174.85 on April 14, 2015.
- The Perrigo 52-week high stock price is 40.28, which is 25.1% above the current share price.
- The Perrigo 52-week low stock price is 25.77, which is 19.9% below the current share price.
- The average Perrigo stock price for the last 52 weeks is 32.84.
Perrigo Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2024 | 31.3159 | 32.8645 | 33.8256 | 25.9884 | 32.1900 | 0.96% |
2023 | 33.0468 | 33.7649 | 38.9171 | 26.4940 | 31.8836 | -2.47% |
2022 | 35.5480 | 36.6046 | 40.5983 | 29.8428 | 32.6909 | -9.80% |
2021 | 39.9412 | 40.6221 | 45.2424 | 33.1775 | 36.2413 | -10.96% |
2020 | 46.1897 | 45.8796 | 54.3864 | 36.5289 | 40.7041 | -11.92% |
2019 | 43.8370 | 35.6050 | 50.5106 | 35.0512 | 46.2106 | 35.65% |
2018 | 66.2722 | 78.2625 | 83.0268 | 32.0885 | 34.0666 | -55.21% |
2017 | 67.6672 | 74.8587 | 77.5269 | 57.3609 | 76.0548 | 5.59% |
2016 | 90.1118 | 122.5906 | 128.2341 | 69.0762 | 72.0288 | -42.14% |
2015 | 147.6611 | 142.9237 | 174.8542 | 124.1219 | 124.4833 | -13.18% |
2014 | 129.5122 | 130.9530 | 144.7506 | 108.5873 | 143.3783 | 9.23% |
2013 | 106.5896 | 91.0100 | 134.1862 | 84.6476 | 131.2609 | 47.94% |
2012 | 91.0566 | 83.7864 | 102.2290 | 79.1784 | 88.7243 | 7.25% |
2011 | 73.3336 | 53.9801 | 87.1192 | 53.5225 | 82.7237 | 54.17% |
2010 | 48.8006 | 34.0317 | 57.6149 | 31.8641 | 53.6581 | 59.73% |
2009 | 24.8910 | 26.4550 | 34.4450 | 15.8458 | 33.5931 | 24.27% |
2008 | 28.9784 | 28.2773 | 35.2808 | 23.6054 | 27.0323 | -7.16% |
2007 | 17.7431 | 14.5215 | 30.0987 | 13.4267 | 29.1173 | 104.11% |
2006 | 13.3526 | 12.3691 | 15.2486 | 11.8456 | 14.2658 | 17.27% |
2005 | 12.6376 | 13.7127 | 15.9684 | 10.4613 | 12.1651 | -12.72% |
2004 | 15.2213 | 12.7213 | 18.6116 | 12.6332 | 13.9387 | 10.69% |
2003 | 11.1180 | 9.9263 | 13.1000 | 8.6176 | 12.5931 | 30.42% |
2002 | 9.4322 | 9.7276 | 11.6747 | 7.5262 | 9.6561 | 2.79% |
2001 | 10.2377 | 6.5566 | 14.5358 | 6.5073 | 9.3938 | 42.74% |
2000 | 5.6025 | 6.4533 | 7.2027 | 4.0977 | 6.5812 | 3.51% |
1999 | 6.5883 | 7.0533 | 7.6494 | 5.7619 | 6.3579 | -9.22% |
1998 | 8.1178 | 11.2297 | 11.3250 | 5.9605 | 7.0040 | -34.13% |
1997 | 10.2255 | 7.1527 | 13.5106 | 7.1527 | 10.6336 | 46.71% |
1996 | 8.6577 | 9.6322 | 11.3250 | 6.9540 | 7.2480 | -23.23% |
1995 | 9.7994 | 9.5369 | 11.0310 | 8.4481 | 9.4415 | -4.96% |
1994 | 14.4785 | 27.2198 | 27.2198 | 8.7421 | 9.9342 | -63.50% |
1993 | 20.2576 | 17.5836 | 27.2198 | 15.3981 | 27.2198 | 52.22% |
1992 | 13.2302 | 11.3250 | 17.8816 | 9.4892 | 17.8816 | 51.26% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $4.263B | $4.656B |
Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $196.909B | 25.56 |
Stryker (SYK) | United States | $136.478B | 33.84 |
Medtronic (MDT) | Ireland | $115.414B | 16.34 |
EssilorLuxottica (ESLOY) | France | $103.810B | 0.00 |
Boston Scientific (BSX) | United States | $100.864B | 33.47 |
Lonza Group Ag (LZAGY) | Switzerland | $44.257B | 0.00 |
Haleon (HLN) | United Kingdom | $39.385B | 30.46 |
ResMed (RMD) | United States | $28.878B | 28.87 |
Terumo (TRUMY) | Japan | $27.930B | 39.32 |
Zimmer Biomet Holdings (ZBH) | United States | $27.196B | 17.54 |
Baxter (BAX) | United States | $21.679B | 15.81 |
Koninklijke Philips (PHG) | Netherlands | $18.879B | 15.06 |
Insulet (PODD) | United States | $11.830B | 62.20 |
Smith & Nephew SNATS (SNN) | United Kingdom | $11.515B | 0.00 |
Demant (WILYY) | Denmark | $11.278B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $9.969B | 29.70 |
BellRing Brands (BRBR) | United States | $7.702B | 41.41 |
Haemonetics (HAE) | United States | $4.271B | 21.84 |
GN Store Nord (GNNDY) | Denmark | $4.150B | 26.87 |
Lantheus Holdings (LNTH) | United States | $4.145B | 10.70 |
Envista Holdings (NVST) | United States | $3.697B | 14.09 |
Prestige Consumer Healthcare (PBH) | United States | $3.606B | 17.05 |
Neogen (NEOG) | United States | $3.347B | 32.21 |
QuidelOrtho (QDEL) | United States | $3.226B | 11.71 |
Green Thumb Industries (GTBIF) | United States | $3.155B | 100.00 |
ICU Medical (ICUI) | United States | $2.484B | 18.71 |
TG Therapeutics (TGTX) | United States | $2.404B | 778.50 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.157B | 0.00 |
Verano Holdings (VRNOF) | United States | $2.151B | 0.00 |
Owens & Minor (OMI) | United States | $2.141B | 20.55 |
InMode (INMD) | Israel | $1.780B | 9.22 |
National Vision Holdings (EYE) | United States | $1.720B | 53.56 |
Agios Pharmaceuticals (AGIO) | United States | $1.636B | 0.00 |
AdaptHealth (AHCO) | United States | $1.510B | 11.36 |
LeMaitre Vascular (LMAT) | United States | $1.499B | 49.78 |
AtriCure (ATRC) | United States | $1.458B | 0.00 |
Warby Parker (WRBY) | United States | $1.303B | 0.00 |
MacroGenics (MGNX) | United States | $0.934B | 0.00 |
Quanterix (QTRX) | United States | $0.873B | 0.00 |
Canopy Growth (CGC) | Canada | $0.870B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.836B | 0.00 |
Evolus (EOLS) | United States | $0.811B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.771B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.716B | 15.47 |
TerrAscend (TSNDF) | Canada | $0.571B | 0.00 |
Valneva SE (VALN) | France | $0.553B | 0.00 |
Jin Medical (ZJYL) | China | $0.543B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.529B | 11.46 |
PetIQ (PETQ) | United States | $0.513B | 19.17 |
OraSure Technologies (OSUR) | United States | $0.470B | 7.77 |
ZimVie (ZIMV) | United States | $0.442B | 27.18 |
Biote (BTMD) | United States | $0.438B | 4.16 |
Surmodics (SRDX) | United States | $0.410B | 44.31 |
Zynex (ZYXI) | United States | $0.405B | 46.59 |
Viemed Healthcare (VMD) | United States | $0.364B | 36.08 |
Cerus (CERS) | United States | $0.325B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.322B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.259B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.252B | 15.36 |
TriSalus Life Sciences (TLSI) | United States | $0.248B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.216B | 0.00 |
Omeros (OMER) | United States | $0.215B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.213B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.189B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.183B | 0.00 |
High Tide (HITI) | Canada | $0.163B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.146B | 0.00 |
Fonar (FONR) | United States | $0.138B | 11.84 |
InterCure (INCR) | Israel | $0.115B | 19.46 |
Societal CDMO (SCTL) | United States | $0.115B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.114B | 0.00 |
FitLife Brands (FTLF) | United States | $0.106B | 20.70 |
MariMed (MRMD) | United States | $0.102B | 0.00 |
Safety Shot (SHOT) | United States | $0.094B | 0.00 |
Chimerix (CMRX) | United States | $0.090B | 0.00 |
Veru (VERU) | United States | $0.089B | 0.00 |
Brainsway (BWAY) | Israel | $0.087B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.084B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.080B | 43.99 |
Zevia PBC (ZVIA) | United States | $0.075B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.065B | 4.25 |
Cytosorbents (CTSO) | United States | $0.050B | 0.00 |
Apyx Medical (APYX) | United States | $0.049B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.048B | 0.00 |
Bright Green (BGXX) | United States | $0.047B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.045B | 0.00 |
Modular Medical (MODD) | United States | $0.043B | 0.00 |
ImmuCell (ICCC) | United States | $0.041B | 0.00 |
United-Guardian (UG) | United States | $0.036B | 13.85 |
FSD PHARMA (HUGE) | Canada | $0.028B | 0.00 |
Agape ATP (ATPC) | $0.027B | 0.00 | |
Exagen (XGN) | United States | $0.027B | 0.00 |
Nephros (NEPH) | United States | $0.024B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.020B | 0.00 |
Flora Growth (FLGC) | United States | $0.018B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
ProSomnus (OSA) | United States | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
GlucoTrack (GCTK) | United States | $0.007B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.007B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.001B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |